BioLase Dental Laser OKd for Soft-Tissue Uses
Medical device maker BioLase Technology Inc. in San Clemente said Wednesday that it has received federal clearance to market its dental laser for a number of other soft tissue procedures.
The company said in a news release that the additional procedures include the treatment of gum disease, a leading oral health problem.
BioLase stock gained 30 cents to close at $5.15 a share on Nasdaq’s small-cap market. The stock has tripled in value this year.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
